The findings indicate that EBV DNA elevates the levels of the pro-inflammatory cytokine IL-17A and amplifies intestinal inflammation in a mouse model of IBD via TLRs 3, 7, and 9 [7,8,9]. Here, IL17A is linked to inflammatory bowel disease.